Award
National Institute of Allergy and Infectious Diseases 5K23AI163350-05
Modeling Risk for Hypogammaglobulinemia, Infections, and Mortality with Chimeric Antigen Receptor (CAR) T-cell Therapy
Recipient
Sara Barmettler, Massachusetts General Hospital
Awarded
May 22, 2025
Identifier
5K23AI163350-05
Award for research on risk modeling related to CAR T-cell therapy to improve patient outcomes by identifying risk factors and developing intervention protocols.
Description
This project focuses on applying advanced clinical epidemiology and simulation modeling to understand the immunologic impact of CAR T-cell therapy, aiming to identify risk factors and develop screening and intervention protocols to improve patient outcomes.